價格 | 詢價 |
包裝 | 5μg |
最小起訂量 | 5μg |
發(fā)貨地 | 上海 |
更新日期 | 2024-11-05 |
中文名稱:Recombinant Human IL-36 Receptor Antagonist | 英文名稱:Recombinant Human IL-36 Receptor Antagonist |
有效期: 一年 | 產(chǎn)品類別: 重組蛋白 細胞因子 |
產(chǎn)品編號 | 產(chǎn)品名稱 | 產(chǎn)品包裝 | 產(chǎn)品價格 |
P5273-5μg | Recombinant Human IL-36 Receptor Antagonist | 5μg | 464.00元 |
Species | Gene ID | Accession | Source | Length | MW | Tag |
Human | 26525 | Q9UBH0 | E. coli | 154aa | 16.8kDa | - |
About this protein | |
Name | Recombinant Human IL-36 Receptor Antagonist (Recombinant Human Interleukin-36 Receptor Antagonist; rHuIL-36RA);重組人白細胞介素36受體拮抗劑 |
Synonyms | IL36RN; FIL1D; IL1F5; IL1HY1; IL1L1; IL1RP3; UNQ1896/PRO4342 |
Purity | >95% by SDS-PAGE and HPLC analyses. |
Biological Activity | Fully biologically active when compared to standard. The ED50 as determined by inhibiting IL-36 beta induced IL-8 secretion by human preadipocytes is less than 1.0μg/ml, corresponding to a specific activity of >1000IU/mg in the presence of 20ng/ml of recombinant human IL-36 beta. |
Physical Appearance | Sterile Filtered White lyophilized (freeze-dried) powder. |
Formulation | Lyophilized from a 0.2μm filtered concentrated solution in PBS, pH7.4. |
Endotoxin | Less than 1EU/μg of rHuIL-36RA as determined by LAL method. |
Reconstitution | We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0mg/ml. Stock solutions should be apportioned into working aliquots and stored at ≤-20℃. Further dilutions should be made in appropriate buffered solutions. |
Category | Cytokine |
Background | Interleukin-36 receptor antagonist (IL-36RA) is a secreted protein which belongs to the interleukin 1 cytokine family (IL-1 family) and it is predominantly expressed in keratinocytes but not in fibroblasts, endothelial cells or melanocytes. IL-36RA has been reported to antagonize the biological activity of IL-36α (IL-1F6), IL-36β (IL-1F8), and IL-36γ (IL-1F9). Furthermore, it could constitute part of an independent signaling system analogous to interleukin-1 alpha (IL-1A), beta (IL-1B) receptor agonist and interleukin-1 receptor type I (IL-1R1). In addition, The receptor for IL-36RA has not been positively identified. Indirect evidence suggests it is IL-1Rrp2. Recombinant human IL-36 RA contains 154 amino acid residues and it shares 91%a.a. sequence identity with murine IL-36RA. |
Amino Acid Sequence | VLSGALCFRM KDSALKVLYL HNNQLLAGGL HAGKVIKGEE ISVVPNRWLD ASLSPVILGV QGGSQCLSCG VGQEPTLTLE PVNIMELYLG AKESKSFTFY RRDMGLTSSF ESAAYPGWFL CTVPEADQPV RLTQLPENGG WNAPITDFYF QQCD |
包裝清單:
產(chǎn)品編號 | 產(chǎn)品名稱 | 包裝 |
P5273-5μg | Recombinant Human IL-36 Receptor Antagonist | 5μg |
P5273-25μg | Recombinant Human IL-36 Receptor Antagonist | 25μg |
P5273-100μg | Recombinant Human IL-36 Receptor Antagonist | 100μg |
P5273-1mg | Recombinant Human IL-36 Receptor Antagonist | 1mg |
- | 說明書 | 1份 |
保存條件:
???????-20℃或更低溫度保存,至少一年有效。由于蛋白的每次凍融均會引起部分失活,所以首次配制成相應濃度的儲存液后(請根據(jù)產(chǎn)品簡介中Reconstitution一欄的信息配制儲存液),須分裝后-20℃或更低溫度凍存,以避免反復凍融。
注意事項:
???????由于有些塑料管壁對某些蛋白有較強的吸附作用,溶液中的蛋白很容易粘附在管壁上,并且粘附后的蛋白很難與管壁分離。而載體蛋白(Carrier protein,如0.1% BSA等)的主要作用是預先封閉塑料管壁上的蛋白結合位點,使細胞因子或重組蛋白不會粘附于管壁。所以一定要使用產(chǎn)品簡介中Reconstitution一欄的信息配制儲存液。
???????本產(chǎn)品僅限于專業(yè)人員的科學研究用,不得用于臨床診斷或治療,不得用于食品或藥品,不得存放于普通住宅內(nèi)。
???????為了您的安全和健康,請穿實驗服并戴一次性手套操作。
成立日期 | 2007-07-19 (18年) | 注冊資本 | 1000.000000萬人民幣 |
員工人數(shù) | 500人以上 | 年營業(yè)額 | ¥ 500萬-1000萬 |
主營行業(yè) | 生化試劑,核苷,核苷酸,寡核苷酸,抗體,蛋白組學,生物活性小分子 | 經(jīng)營模式 | 試劑 |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
¥646 |
VIP5年
|
上??道噬锟萍加邢薰?/div>
|
2024-11-07 | |
詢價 |
VIP3年
|
紹興市均宇生物科技有限公司
|
2024-11-07 | |
¥4920.00 |
VIP9年
|
北京索萊寶科技有限公司
|
2024-11-07 | |
¥646 |
VIP5年
|
上海康朗生物科技有限公司
|
2024-11-07 |